These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23263339)

  • 1. Detection of carboxyhemefibrinogen and methemefibrinogen in a patient with thrombosis of a HeartMate II ventricular assist device.
    Smith MC; Nielsen VG
    ASAIO J; 2013; 59(1):93-5. PubMed ID: 23263339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.
    Matika RW; Nielsen VG; Steinbrenner EB; Sussman AN; Madhrira M
    ASAIO J; 2014; 60(6):716-21. PubMed ID: 25232771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Assist Device-Associated Carbon Monoxide and Iron-Enhanced Hypercoagulation: Impact of Concurrent Disease.
    Nielsen VG; Sobieski MA; Slaughter MS
    ASAIO J; 2015; 61(4):417-23. PubMed ID: 25710774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis from aortic regurgitation mimicking pump thrombosis in a patient with a HeartMate II left ventricular assist device: a case report.
    Gopalan RS; Arabia FA; Noel P; Chandrasekaran K
    ASAIO J; 2012; 58(3):278-80. PubMed ID: 22285976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease.
    Thompson JL; Nielsen VG; Castro AR; Chen A
    J Thromb Thrombolysis; 2015 May; 39(4):532-5. PubMed ID: 25169134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
    Nielsen VG; Arkebauer MR; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic tumor effects on plasmatic coagulation: role of hemeoxygenase-1.
    Nielsen VG; Gharagozloo F; Matika RW; Kim S; Zelman EA; Steinbrenner EB
    Lung Cancer; 2014 Feb; 83(2):288-91. PubMed ID: 24355260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased carbon monoxide production by hemeoxygenase-1 caused by device-mediated hemolysis: thrombotic phantom menace?
    Nielsen VG; Pearson EC; Smith MC
    Artif Organs; 2013 Nov; 37(11):1008-14. PubMed ID: 23865494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
    Zhang J; Chen Z; Griffith BP; Wu ZJ
    Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide.
    Nielsen VG; Hafner DT; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):405-10. PubMed ID: 23429254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity.
    Nielsen VG; Galvani CA; Boyle PK; Steinbrenner EB; Matika RW
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):200-4. PubMed ID: 25101516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
    Olver CS; Nielsen VG
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
    Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombus formation in a HeartMate II left ventricular assist device.
    Meyer AL; Kuehn C; Weidemann J; Malehsa D; Bara C; Fischer S; Haverich A; Strüber M
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):203-4. PubMed ID: 18179943
    [No Abstract]   [Full Text] [Related]  

  • 18. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.
    Badiye A; Hernandez GA; Chaparro S
    ASAIO J; 2014; 60(3):361-5. PubMed ID: 24614354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis and failure of a HeartMate II device in the absence of alarms.
    Bashir J; Cheung A; Kaan A; Kearns M; Ibey A; Ignaszewski A
    J Heart Lung Transplant; 2011 Oct; 30(10):1197-9. PubMed ID: 21764605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Malehsa D; Meyer AL; Bara C; Strüber M
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.